| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1019050745 |
| P356 | DOI | 10.1007/S12020-010-9383-8 |
| P953 | full work available at URL | http://link.springer.com/article/10.1007/s12020-010-9383-8/fulltext.html |
| http://link.springer.com/content/pdf/10.1007/s12020-010-9383-8 | ||
| http://link.springer.com/content/pdf/10.1007/s12020-010-9383-8.pdf | ||
| P698 | PubMed publication ID | 20972736 |
| P2093 | author name string | Yong Feng | |
| Fan Yu | |||
| Hui-qing Li | |||
| Lu-lu Chen | |||
| Tian-shu Zeng | |||
| Yun-fei Liao | |||
| P2860 | cites work | Metformin Increases AMP-Activated Protein Kinase Activity in Skeletal Muscle of Subjects With Type 2 Diabetes | Q22241283 |
| Role of AMP-activated protein kinase in mechanism of metformin action | Q22241898 | ||
| Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration | Q28207902 | ||
| Circulating endothelial progenitor cells and cardiovascular outcomes | Q28271167 | ||
| Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group | Q29547282 | ||
| Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes | Q29547541 | ||
| 10-year follow-up of intensive glucose control in type 2 diabetes | Q29615973 | ||
| Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus | Q29616284 | ||
| The pathobiology of diabetic complications: a unifying mechanism | Q29617766 | ||
| Vascular benefits of gliclazide beyond glycemic control. | Q34082506 | ||
| Oral antidiabetic agents as cardiovascular drugs | Q36697741 | ||
| Significance of endothelial progenitor cells in subjects with diabetes. | Q36727790 | ||
| Endothelial progenitor cells and vascular biology in diabetes mellitus: current knowledge and future perspectives. | Q37065482 | ||
| Circulating endothelial progenitor cells, vascular function, and cardiovascular risk | Q39513285 | ||
| Effect of green tea consumption on endothelial function and circulating endothelial progenitor cells in chronic smokers | Q40304200 | ||
| Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes | Q44231053 | ||
| Vascular dysfunction and reduced circulating endothelial progenitor cells in young healthy UK South Asian men. | Q44670183 | ||
| Mortality in type 2 diabetic subjects prescribed metformin and sulphonylurea drugs in combination: cohort study | Q44888738 | ||
| Relation of metformin treatment to clinical events in diabetic patients undergoing percutaneous intervention | Q44912661 | ||
| Impact of oral antihyperglycemic therapy on all-cause mortality among patients with diabetes in the Veterans Health Administration | Q45332382 | ||
| Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. | Q46464366 | ||
| Antioxidant and vascular effects of gliclazide in type 2 diabetic rats fed high-fat diet | Q46670844 | ||
| Standards of medical care in diabetes--2008. | Q46828447 | ||
| Inseparably tied: functional and antioxidative capacity of endothelial progenitor cells | Q46925917 | ||
| Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetic subjects | Q46926316 | ||
| Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin | Q46981921 | ||
| The impact of the capability of circulating progenitor cell to differentiate on myocardial salvage in patients with primary acute myocardial infarction. | Q51168559 | ||
| The peroxisome proliferator-activated receptor-gamma agonist pioglitazone increases number and function of endothelial progenitor cells in patients with coronary artery disease and normal glucose tolerance. | Q51467833 | ||
| High glucose impairs early and late endothelial progenitor cells by modifying nitric oxide-related but not oxidative stress-mediated mechanisms. | Q53563228 | ||
| Reduced numbers of circulating endothelial progenitor cells in patients with coronary artery disease associated with long-term statin treatment | Q61612306 | ||
| Number and Function of Endothelial Progenitor Cells as a Marker of Severity for Diabetic Vasculopathy | Q63285824 | ||
| Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures | Q78570627 | ||
| Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes | Q79843154 | ||
| The effects of metformin on metabolic and cardiovascular risk factors in nonobese women with polycystic ovary syndrome | Q80709031 | ||
| A novel indicator of widespread endothelial damage and ischemia in diabetic patients: ischemia-modified albumin | Q84590972 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | metformin | Q19484 |
| endothelium | Q111140 | ||
| gliclazide | Q290001 | ||
| P304 | page(s) | 266-275 | |
| P577 | publication date | 2010-10-23 | |
| P1433 | published in | Endocrine | Q15757048 |
| P1476 | title | Effects of metformin plus gliclazide compared with metformin alone on circulating endothelial progenitor cell in type 2 diabetic patients | |
| P478 | volume | 38 |
| Q49083280 | Co-extrusion as a processing technique to manufacture a dual sustained release fixed-dose combination product |
| Q28082426 | Diabetes, Endothelial Dysfunction, and Vascular Repair: What Should a Diabetologist Keep His Eye on? |
| Q38160887 | Early combination therapy for the treatment of type 2 diabetes mellitus: systematic review and meta-analysis |
| Q49395738 | Effect of combined gliclazide/metformin treatment on oxidative stress, lipid profile, and hepatorenal functions in type 2 diabetic patients |
| Q40844288 | Effects of sulfonylureas on lipids in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials |
| Q58571958 | Endothelial Progenitor Cells Biology in Diabetes Mellitus and Peripheral Arterial Disease and their Therapeutic Potential |
| Q92382353 | Identification of differentially expressed genes in the endothelial precursor cells of patients with type 2 diabetes mellitus by bioinformatics analysis |
| Q28385776 | Insulin sensitizers prevent fine particulate matter-induced vascular insulin resistance and changes in endothelial progenitor cell homeostasis |
| Q37074243 | Irisin Increased the Number and Improved the Function of Endothelial Progenitor Cells in Diabetes Mellitus Mice |
| Q36562557 | Measurements of CD34+/CD45-dim Stem Cells Predict Healing of Diabetic Neuropathic Wounds |
| Q64083270 | Metformin Inhibits the Expression of Biomarkers of Fibrosis of EPCs In Vitro |
| Q49243537 | Metformin accelerates wound healing in type 2 diabetic db/db mice |
| Q37209499 | Metformin improves circulating endothelial cells and endothelial progenitor cells in type 1 diabetes: MERIT study |
| Q37018236 | Metformin improves the angiogenic functions of endothelial progenitor cells via activating AMPK/eNOS pathway in diabetic mice |
| Q38460480 | Postprandial Dysmetabolism and Oxidative Stress in Type 2 Diabetes: Pathogenetic Mechanisms and Therapeutic Strategies |
| Q37956885 | Stem cell senescence and regenerative paradigms. |
| Q55265221 | The synergistic effects of saxagliptin and metformin on CD34+ endothelial progenitor cells in early type 2 diabetes patients: a randomized clinical trial. |
Search more.